Drugs / AZD2551
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00860353 | Feb → May 2009 | — | AstraZeneca | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD2551 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00860353 ↗ |
| Route | Oral | “Single dose of oral solution.” NCT00860353 ↗ |